Follow
Dr Edward Shelton
Dr Edward Shelton
Monash Health
Verified email at yarragastro.com.au
Title
Cited by
Cited by
Year
Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicenter cohort
E Shelton, JR Allegretti, B Stevens, M Lucci, H Khalili, DD Nguyen, J Sauk, ...
Inflammatory bowel diseases 21 (12), 2879-2885, 2015
2032015
Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: a systematic review and meta-analysis
E Shelton, D Laharie, FI Scott, R Mamtani, JD Lewis, JF Colombel, ...
Gastroenterology 151 (1), 97-109. e4, 2016
1522016
New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease
E Shelton, K Chaudrey, J Sauk, H Khalili, R Masia, DD Nguyen, V Yajnik, ...
Alimentary pharmacology & therapeutics 41 (10), 972-979, 2015
652015
Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
E Shelton, M Yong, S Cohney
Nephrology 14 (7), 696-699, 2009
512009
Safety and Efficacy of Teduglutide (Gattex) in patients with Crohn’s disease and need for parenteral support due to short bowel syndrome associated intestinal failure
B Kochar, MD Long, E Shelton, L Young, FA Farraye, V Yajnik, H Herfarth
Journal of clinical gastroenterology 51 (6), 508, 2017
452017
Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
HH Bharati Kochar, Millie D Long, Edward Shelton, Lorraine Young, Francis A ...
Journal of Clinical Gastroenterology, 2016
45*2016
A randomized controlled study of trimethoprim‐sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients
S Lontos, E Shelton, PW Angus, R Vaughan, SK Roberts, A Gordon, ...
Journal of digestive diseases 15 (5), 260-267, 2014
422014
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure
E Flanagan, PR Gibson, EK Wright, GT Moore, MP Sparrow, W Connell, ...
Alimentary Pharmacology & Therapeutics 52 (10), 1551-1562, 2020
402020
Risk stratification of upper GI bleeding with an esophageal capsule
S Chandran, A Testro, P Urquhart, R La Nauze, S Ong, E Shelton, ...
Gastrointestinal endoscopy 77 (6), 891-898, 2013
382013
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
G Maconi, C Bosetti, A De Monti, RK Boyapati, E Shelton, N Piazza, ...
Digestive and Liver Disease 53 (3), 263-270, 2021
262021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
JD Schulberg, EK Wright, BA Holt, AL Hamilton, TR Sutherland, AL Ross, ...
The Lancet Gastroenterology & Hepatology, 2021
212021
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir
J Trevillyan, P Angus, E Shelton, J Whitlam, F Ierino, J Pavlovic, ...
Antimicrobial agents and chemotherapy 57 (8), 4058-4060, 2013
192013
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive
E Flanagan, EK Wright, MP Sparrow, GT Moore, WR Connell, P De Cruz, ...
Inflammatory bowel diseases, 2021
102021
Gastrointestinal: balloon pancreatitis
E Shelton, P Froomes, MA Fink
Journal of gastroenterology and hepatology 27 (5), 986-986, 2012
72012
Immunomodulator use does not prevent first loss of response to anti-TNF therapy in inflammatory bowel disease: long term outcomes in a real-world cohort
P Varma, AS Rajadurai, DQ Holt, DA Devonshire, CP Desmond, ...
Intern Med J 49, 685-810, 2018
62018
Tu1359 Efficacy of Vedolizumab As Induction Therapy in Refractory IBD Patients Following Multiple Anti-TNF Therapy Failures
BW Stevens, E Shelton, J Sauk, H Khalili, DD Nguyen, M White-Guthro, ...
Gastroenterology 148 (4), S-869, 2015
42015
Hepatic Fibrosis Is Common in ‚-Thalassaemia and Is Associated with Current and Historical Iron Loading and Hepatitis C
E Shelton, CP Chong, L Shochet, SY Ong, DK Bowden, V Knight, ...
Journal of Hepatitis 2 (1), 2016
32016
Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT Randomised†…
J Schulberg, E Wright, B Holt, T Sutherland, A Ross, A Hamilton, S Vogrin, ...
JOURNAL OF CROHNS & COLITIS 15, S328-S330, 2021
22021
Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis
RD Little, IE Chu, EP van der Zanden, E Flanagan, SJ Bell, PR Gibson, ...
Journal of Crohn's and Colitis 13 (12), 1527-1536, 2019
22019
P300 Crohn’s Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. The STRIDENT†…
J Schulberg, E Wright, B Holt, T Sutherland, A Ross, A Hamilton, S Vogrin, ...
Journal of Crohn's and Colitis 15 (Supplement_1), S328-S330, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20